Oxford Immunotec Global PLC (OXFD1)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
CEO:
Peter James Wrighton-Smith
Employees:
210
94C INNOVATION DRIVE, MILTON PARK, ABINGDON, UNITED KINGDOM OX14 4RZ
44 01235 442780

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Oxford Immunotec Global Plc is a medical diagnostics company, which engages in the provisions of innovative tests in the field of immunology. It provides T-SPOT technology to measure the responses of specific immune cells, known as T cells, to inform the diagnosis, prognosis and monitoring of patients with immunologically controlled diseases. The company was founded in 2002 and is headquartered in Abingdon, the United Kingdom.

Data derived from most recent annual or quarterly report
Market Cap 570.9 Million Shares Outstanding25.962 Million Avg 30-day Volume 374.819 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.61
Price to Revenue5.2885 Debt to Equity0.0 EBITDA-19.181 Million
Price to Book Value1.5843 Operating Margin-31.515300000000003 Enterprise Value142.386 Million
Current Ratio15.962 EPS Growth-1.125 Quick Ratio14.547
1 Yr BETA 0.6676 52-week High/Low 0.0 / Profit Margin-30.51
Operating Cash Flow Growth31.4107 Altman Z-Score9.7519 Free Cash Flow to Firm -12.561 Million
View SEC Filings from OXFD1 instead.

View recent insider trading info

Funds Holding OXFD1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OXFD1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2021-03-08:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2021-03-02:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2021-02-26:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-01-07:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-11-30:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-06-25:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2020-05-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-04-21:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    TOBIN JAMES R

    0 2021-03-08 0

    ROSENMAN HERM

    0 2021-03-08 0

    SANDBERG RICHARD A

    0 2021-03-08 0

    RANDALL PATRICIA

    0 2021-03-08 0

    BALTHROP PATRICK J

    0 2021-03-08 0

    ANDREWS RONALD ASBURY

    0 2021-03-08 0

    WALTON ANDREW SCOTT

    0 2021-03-08 0

    WRIGHTON-SMITH PETER CHIEF EXECUTIVE OFFICER

    0 2021-03-08 0

    KLAUSNER MARK R.

    0 2021-03-08 0

    MCLAUGHLIN MATTHEW T E CHIEF FINANCIAL OFFICER

    0 2021-03-08 0

    KIDD JANET LOUISE GENERAL COUNSEL

    0 2021-03-08 0

    LINN STEFAN C CHIEF OPERATING OFFICER

    • Officer
    96,301 2020-03-11 0

    KEILEY ELIZABETH M SVP & GENERAL COUNSEL

    • Officer
    26,928 2019-03-04 0

    ALTIERI RICHARD M. CHIEF FINANCIAL OFFICER

    • Officer
    207,965 2019-01-01 0

    WENSTRUP RICHARD CHIEF MEDICAL OFFICER

    • Officer
    22,992 2018-03-15 0

    EDWARDSON PETER CHIEF OPERATIONS OFFICER

    • Officer
    92,905 2017-08-15 0

    SPOTTS STEPHEN L

    • Director
    0 2017-06-06 0

    SCHROEDER JEFF R. CHIEF COMMERCIAL OFFICER

    • Officer
    127,147 2017-05-08 0

    CLARUS LIFESCIENCES I, L.P.

    CLARUS VENTURES I MANAGEMENT, L.P.

    CLARUS VENTURES I, LLC

    GALAKATOS NICHOLAS

    HENNER DENNIS

    LIPTAK ROBERT

    SIMON NICHOLAS

    WHEELER KURT

    • 10% Owner
    No longer subject to file 2015-06-15 0

    NEW LEAF VENTURES II, L.P.

    NEW LEAF VENTURE ASSOCIATES II, L.P.

    NEW LEAF VENTURE MANAGEMENT II, L.L.C.

    CHAMBON PHILIPPE O.

    NIEDEL JAMES

    HUNT RONALD

    DELAGARDELLE JEANI

    RATCLIFFE LIAM

    • Director
    • FORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNER
    No longer subject to file 2013-11-27 0

    STEINMETZ MICHAEL

    • Director
    • 10% Owner
    2,579,062 2013-11-21 0

    LATHI VIJAY K

    • Director
    • 10% Owner
    1,377,497 2013-11-21 0

    PITCHFORD NIGEL A.

    • Director
    833,448 2013-11-21 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 22:15:03 UTC -0.6616 0.7316 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 21:45:03 UTC -0.6616 0.7316 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 21:15:03 UTC -0.6616 0.7316 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 20:45:03 UTC -0.6625 0.7325 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 20:15:03 UTC -0.6625 0.7325 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 19:45:02 UTC -0.6625 0.7325 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 19:15:02 UTC -0.6625 0.7325 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 18:45:02 UTC -0.6625 0.7325 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 18:15:02 UTC -0.6625 0.7325 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 17:45:03 UTC -0.6625 0.7325 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 17:15:03 UTC -0.6625 0.7325 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 16:45:02 UTC -0.6625 0.7325 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 16:15:03 UTC -0.6625 0.7325 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 15:45:02 UTC -0.6625 0.7325 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 15:15:03 UTC -0.6625 0.7325 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 14:45:03 UTC -0.6616 0.7316 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 14:15:03 UTC -0.6616 0.7316 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 13:45:03 UTC -0.6616 0.7316 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 13:15:03 UTC -0.6616 0.7316 1200000
    OXFORD IMMUNOTEC GLOBAL PLC OXFD 2021-03-08 12:45:03 UTC -0.6616 0.7316 1200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments